Literature DB >> 29688897

Frequency and Predictors of Communication About High Blood Pressure in Rheumatoid Arthritis Visits.

Christie Michels Bartels, Heather Johnson, Katya Alcaraz Voelker1, Alexis Ogdie2, Patrick McBride, Elizabeth A Jacobs, Ying-Qi Zhao3, Maureen Smith.   

Abstract

BACKGROUND/
OBJECTIVE: Given heightened cardiovascular disease (CVD) risk in rheumatoid arthritis (RA) and that higher blood pressure (BP) represents greater CVD risk, we hypothesized that higher BP would predict more BP-related communication in rheumatology visits. We examined predictors of documented BP communication during RA clinic visits.
METHODS: This was a retrospective cohort study of RA patients identified in electronic health record records with uncontrolled hypertension (HTN) receiving both primary and rheumatology care. Trained abstractors reviewed RA visit notes for "BP communication" using a standardized tool to elicit documentation about BP or HTN beyond recording vital signs. We used multivariate logistic regression to examine the impact of BP category (American Heart Association: ideal normotension, pre-HTN, and stages I and II HTN) on odds ratios (95% confidence intervals) of BP communication.
RESULTS: Among 1267 RA patients, 40% experienced BP elevations meeting the definition of uncontrolled HTN. Of 2677 eligible RA visits, 22% contained any documented BP communication. After adjustment, models predicted only 31% of visits with markedly high BPs 160/100 mm Hg or greater would contain BP communication. Compared with stage I, stage II elevation did not significantly increase communication (odds ratio, 2.0 [95% confidence interval, 1.4-2.8] vs. 1.5 [1.2-2.2]), although both groups' odds exceeded pre-HTN and normotension. Less than 10% of eligible visits resulted in documented action steps recommending follow-up of high BP.
CONCLUSIONS: Regardless of BP magnitude, most RA clinic visits lacked documented communication about BP despite compounded CVD risk. Future work should study how rheumatology clinics can facilitate follow-up of high BPs to address HTN as the most common and reversible CVD risk factor.

Entities:  

Mesh:

Year:  2018        PMID: 29688897      PMCID: PMC5962363          DOI: 10.1097/RHU.0000000000000726

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  34 in total

1.  Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a greek cohort study.

Authors:  John Serelis; Demosthenes B Panagiotakos; Maria Mavrommati; Fotini N Skopouli
Journal:  J Rheumatol       Date:  2010-11-15       Impact factor: 4.666

2.  Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures.

Authors:  J N Katz; J Barrett; M H Liang; A M Bacon; H Kaplan; R I Kieval; S M Lindsey; W N Roberts; D M Sheff; R T Spencer; A L Weaver; J A Baron
Journal:  Arthritis Rheum       Date:  1997-09

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

4.  Identifying hypertension-related comorbidities from administrative data: what's the optimal approach?

Authors:  Ann M Borzecki; Ashley T Wong; Elaine C Hickey; Arlene S Ash; Dan R Berlowitz
Journal:  Am J Med Qual       Date:  2004 Sep-Oct       Impact factor: 1.852

5.  Quality of care for patients with rheumatoid arthritis.

Authors:  C H MacLean; R Louie; B Leake; D F McCaffrey; H E Paulus; R H Brook; P G Shekelle
Journal:  JAMA       Date:  2000 Aug 23-30       Impact factor: 56.272

6.  Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis.

Authors:  Christie M Bartels; Amy J H Kind; Christine Everett; Matthew Mell; Patrick McBride; Maureen Smith
Journal:  Arthritis Rheum       Date:  2011-05

7.  Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate.

Authors:  Vasileios F Panoulas; Tracey E Toms; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; Athanasios Kosovitsas; Haralampos J Milionis; Karen M J Douglas; Holly John; George D Kitas
Journal:  Atherosclerosis       Date:  2009-08-31       Impact factor: 5.162

8.  Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis.

Authors:  Tracy U Nguyen-Oghalai; Sonya E Hunnicutt; Sarah Toombs Smith; Rashmi Maganti; Terry A McNearney
Journal:  J Clin Rheumatol       Date:  2007-12       Impact factor: 3.517

9.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

Review 10.  The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Leena R Baghdadi; Richard J Woodman; E Michael Shanahan; Arduino A Mangoni
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

View more
  3 in total

1.  Connecting Rheumatology Patients to Primary Care for High Blood Pressure: Specialty Clinic Protocol Improves Follow-up and Population Blood Pressures.

Authors:  Christie M Bartels; Edmond Ramly; Heather M Johnson; Diane R Lauver; Daniel J Panyard; Zhanhai Li; Emmanuel Sampene; Kristin Lewicki; Patrick E McBride
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04       Impact factor: 4.794

2.  Interactive and Participatory Audit and Feedback (IPAF): theory-based development and multi-site implementation outcomes with specialty clinic staff.

Authors:  Edmond Ramly; Diane R Lauver; Andrea Gilmore-Bykovskyi; Christie M Bartels
Journal:  Implement Sci Commun       Date:  2021-05-31

3.  Significant Gains in Rheumatoid Arthritis Quality Measures Among RISE Registry Practices.

Authors:  Zara Izadi; Gabriela Schmajuk; Milena Gianfrancesco; Meera Subash; Michael Evans; Laura Trupin; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12-27       Impact factor: 4.794

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.